User profiles for Emmanuel B. Walter

Emmanuel Walter

Verified email at mc.duke.edu
Cited by 9718

[HTML][HTML] Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age

EB Walter, KR Talaat, C Sabharwal… - … England Journal of …, 2022 - Mass Medical Soc
Background Safe, effective vaccines against coronavirus disease 2019 (Covid-19) are urgently
needed in children younger than 12 years of age. Methods A phase 1, dose-finding study …

[HTML][HTML] Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents

…, S Lockhart, JL Perez, EB Walter… - … England Journal of …, 2021 - Mass Medical Soc
Background Until very recently, vaccines against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) had not been authorized for emergency use in persons younger than …

[HTML][HTML] Evaluation of BNT162b2 Covid-19 vaccine in children younger than 5 years of age

…, GC Paulsen, Y Maldonado, EB Walter… - … England Journal of …, 2023 - Mass Medical Soc
Background Safe and effective vaccines against coronavirus disease 2019 (Covid-19) are
urgently needed in young children. Methods We conducted a phase 1 dose-finding study and …

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

…, P Pinell, HA Hammill, GK Swamy, EB Walter… - Jama, 2014 - jamanetwork.com
… Dr Walter reported serving as a consultant and advisor for Merck; serving as a speaker for
Sanofi Pasteur; and conducting clinical trials sponsored by GlaxoSmithKline, Merck, Novartis, …

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

…, PR Dormitzer, BF Haynes, EB Walter… - Proceedings of the …, 2011 - National Acad Sciences
Seasonal antigenic drift of circulating influenza virus leads to a requirement for frequent
changes in vaccine composition, because exposure or vaccination elicits human antibodies with …

[HTML][HTML] A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled …

…, J Feser, A Naficy, DI Bernstein, J Guptill, EB Walter… - Nature medicine, 2021 - nature.com
Seasonal influenza viruses constantly change through antigenic drift and the emergence of
pandemic influenza viruses through antigenic shift is unpredictable. Conventional influenza …

[HTML][HTML] Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo …

…, HN Imlay, JJ Engemann, EB Walter… - The lancet respiratory …, 2021 - thelancet.com
Background Functional impairment of interferon, a natural antiviral component of the
immune system, is associated with the pathogenesis and severity of COVID-19. We aimed to …

[HTML][HTML] Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements

…, TC Gurley, MA Moody, BF Haynes, EB Walter… - Cell host & …, 2014 - cell.com
B cells produce a diverse antibody repertoire by undergoing gene rearrangements. Pathogen
exposure induces the clonal expansion of B cells expressing antibodies that can bind the …

Case series of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination—United States, December 2020 to August 2021

…, S Sharma, KR Talaat, EB Walter… - Annals of internal …, 2022 - acpjournals.org
Background: Thrombosis with thrombocytopenia syndrome (TTS) is a potentially life-threatening
condition associated with adenoviral-vectored COVID-19 vaccination. It presents …

Short-vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial

DJ Williams, CB Creech, EB Walter, JM Martin… - JAMA …, 2022 - jamanetwork.com
Importance Childhood community-acquired pneumonia (CAP) is usually treated with 10 days
of antibiotics. Shorter courses may be effective with fewer adverse effects and decreased …